These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5632982)

  • 1. 6-azauracil derivative as liver function test in the course of cyclophosphamide treatment.
    Timar M; Hädrich I; Banu E; Nitelea I; Teodorescu M
    Farmaco Prat; 1967 Jul; 22(7):403-9. PubMed ID: 5632982
    [No Abstract]   [Full Text] [Related]  

  • 2. 5M6AU as a liver function test during drug treatment.
    Timar M; Hadrich I; Nitelea I; Teodorescu M; Mogos I
    Farmaco Prat; 1968 May; 23(5):267-75. PubMed ID: 5756504
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of 5-mercapto-6-azauracil and cysteine on the toxicity of cyclophosphamide].
    Timar M; Vrejoiu G; Teodorescu M; Eneskcu L
    Farmakol Toksikol; 1968; 31(6):741-2. PubMed ID: 5756534
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of action of 5-mercapto-6-azauracil].
    Timar M; Gedrikh I; Vrezhoiu G; Peushesku E
    Farmakol Toksikol; 1969; 32(5):602-4. PubMed ID: 5395562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of pretreatment with cyclophosphamide, ribo-azauracil and mercaleukin on experimental metastases in a syngeneic tumour-host-system: II. Chemically induced sarcomas of mouse and rat].
    Elbe B; Nowak C; Arnold W; Bender E
    Arch Geschwulstforsch; 1973; 41(2):137-45. PubMed ID: 4800210
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of alkylants, antimetabolites and chloroquine on oxydative biotransformation reactions and on the excretion of ascorbic acid in the rat.
    Traeger A; Bauer B; Klinger W; Ankermann H
    Acta Biol Med Ger; 1973; 30(3):423-34. PubMed ID: 4800889
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of the pathogenic effect of 5-azauracil and 6-azauracil on chick embryogenesis].
    Kosmachevskaia ZA
    Arkh Anat Gistol Embriol; 1968 Mar; 54(3):85-92. PubMed ID: 5694855
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of uracil aza-derivatives in Saccharomyces cervisiae. 3. Study of catabolism products of 6-azauracil].
    Wisenfeld M; Crokaert R
    Bull Soc Chim Biol (Paris); 1969 Oct; 51(5):951-60. PubMed ID: 5394614
    [No Abstract]   [Full Text] [Related]  

  • 9. 1,3-dimethyl-5-fluoro-6-azauracil and some 5-bromo-6-azauracil derivatives.
    Durr GJ
    J Med Chem; 1967 Mar; 10(2):288-9. PubMed ID: 6071870
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of aza-derivatives of uracil on Saccharomyces cerevisiae. II. Differences in the metabolic behavior of the normal strain and a strain resistant to 6-azauracil].
    Wiesenfeld M; Crokaert R
    Bull Soc Chim Biol (Paris); 1967; 49(2):191-203. PubMed ID: 6072541
    [No Abstract]   [Full Text] [Related]  

  • 11. [The induction of latent liver damage by cyclophosphamide].
    Kropacová K; Misurová E
    Biull Eksp Biol Med; 1989 Jun; 107(6):756-8. PubMed ID: 2790178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of metabolic changes in the liver on the cytotoxic activity of cyclophosphamide in the incisor of rats].
    Rosenfeld E; Ponsold W; Hoffmann P
    Biomed Biochim Acta; 1988; 47(8):761-6. PubMed ID: 3240306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavior of the hepatocytes of normal rats subjected to treatment with sublethal doses of cyclophosphamide. Observations with the electron microscope].
    Cuccurullo L; Covelli V
    Riv Anat Patol Oncol; 1964 Jul; 26(1):39-61. PubMed ID: 5830209
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic treatment with azathioprine and cyclophosphamide in rats: structural and functional effects on small intestine and liver.
    Celle G; Dodero M; Bogliolo G; Mansi C; Pannacciulli I
    G E N; 1977; 31(3):179-84. PubMed ID: 97125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatotoxicity of cyclophosphamide in the rat after prolonged treatment: a histomorphological study].
    Gismondi C; Dabove L; Dovì M; Picciotto A; Savarino V; Testa R; Mansi C
    Boll Soc Ital Biol Sper; 1980 Nov; 56(21):2166-72. PubMed ID: 7213479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differences in the metabolic behavior of a normal strain of "Saccharomyces cerevisiae" and of a strain resistant to 6-azauracil].
    Wiesenfeld M; Crokaert R
    Arch Int Physiol Biochim; 1966 Nov; 74(5):947-8. PubMed ID: 4166013
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of (4,5- 14 C)-6-azauridine in rats with adjuvant-induced polyarthritis.
    Perlík F; Elis J
    Physiol Bohemoslov; 1971; 20(2):181-4. PubMed ID: 4255721
    [No Abstract]   [Full Text] [Related]  

  • 18. [Derivatives of 3,5-dihydroxy-1,2,4-triazines (6-azauracil) with apparent cytostatic action].
    CRISTESCU C; MARCUS J
    Pharmazie; 1961 Mar; 16():135-7. PubMed ID: 13696490
    [No Abstract]   [Full Text] [Related]  

  • 19. The anticancerous action of 6-azauracil (3, 5-dioxo-2, 3, 4, 5-tetrahydro-1, 2, 4-triazine).
    SORM F; JAKUBOVIC A; SLECHTA L
    Experientia; 1956 Jul; 12(7):271-2. PubMed ID: 13344447
    [No Abstract]   [Full Text] [Related]  

  • 20. The induction of tumors in the hybrid Nicotiana glauca x N. langsdorffii plants by 6-azauracil and its reversal by uracil and actinomycin D.
    Buiatti M
    Cancer Res; 1968 Feb; 28(2):166-9. PubMed ID: 5694400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.